The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania
Background. To provide data on the use of anti-cyclic citrullinated peptide antibody (anti-CCP) and other routinely used clinical parameters and to assess the impact of anti-CCP status on therapeutic decisions, an observational study was conducted in patients with rheumatoid arthritis (RA). Methods...
Main Authors: | Sigita Stropuvienė, Asta Baranauskaitė, Loreta Bukauskienė, Jolanta Zaikauskienė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2018-08-01
|
Series: | Acta Medica Lituanica |
Subjects: | |
Online Access: | https://www.journals.vu.lt/AML/article/view/21307 |
Similar Items
-
Effect of anti - cyclic citrullinated peptide antibody and Rheumatoid factor on clinical diseases activity index in patients with rheumatoid arthritis
by: Jafarzadeh L, et al.
Published: (2015-09-01) -
The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients
by: Nasrin Iranshahi, et al.
Published: (2018-01-01) -
Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
by: H.M. Farouk, et al.
Published: (2009-09-01) -
Associação do anticorpo anticitrulina e gravidade da artrite reumatóide Association of anti-cyclic citrullinated peptide antibody and severe rheumatoid arthritis
by: Aldifran Ferreira da Silva, et al.
Published: (2006-06-01) -
Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
by: Prabhakar Singh, et al.
Published: (2020-01-01)